7-hydroxystaurosporine has been researched along with Osteogenic Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aslanian, AS; Lees, JA; Reinhardt, HC; Yaffe, MB | 1 |
| Chen, TY; Huang, BM; Kang, FC; Kuan, TS; Lien, WC; Lin, TC; Sheu, SY; Wang, CY; Yu, CH | 1 |
2 other study(ies) available for 7-hydroxystaurosporine and Osteogenic Sarcoma
| Article | Year |
|---|---|
p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Ataxia Telangiectasia Mutated Proteins; Bone Neoplasms; cdc25 Phosphatases; Cell Cycle Proteins; Cell Division; Cell Survival; Cells, Cultured; Cisplatin; DNA Damage; DNA Repair; DNA-Binding Proteins; Doxorubicin; G2 Phase; Humans; Intracellular Signaling Peptides and Proteins; Mice; Mice, Knockout; Mice, Nude; Mitosis; Neoplasms, Experimental; Osteosarcoma; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase C; Protein Kinases; Protein Serine-Threonine Kinases; S Phase; Signal Transduction; Staurosporine; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Ultraviolet Rays | 2007 |
7-hydroxy-staurosporine, UCN-01, induces DNA damage response, and autophagy in human osteosarcoma U2-OS cells.
Topics: Autophagy; Bone Neoplasms; Cell Line, Tumor; DNA Damage; Humans; Osteosarcoma; Staurosporine | 2018 |